Hansen, Henrik Bjork,Grunnet, Morten,Bentzen, Bo Hjorth,Hyveled-Nielsen, Lars,Lassen, Jorgen Buus,Sundgreen, Claus
申请号：
AU2013220424
公开号：
AU2013220424B2
申请日:
2013.02.14
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective combination of Tesofensine and Metoprolol for preventing the cardiovascular side effects of Tesofensine, while leaving the robust inhibitory efficacy on food intake and body weight loss unaffected.
